TRANSITION AGREEMENT AND RELEASETransition Agreement and Release • March 23rd, 2022 • Sierra Oncology, Inc. • Pharmaceutical preparations • Massachusetts
This Transition Agreement and Release (“Agreement”) is made by and between Mark Kowalski (“Employee”) and Sierra Oncology, Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
CONSULTING AGREEMENTConsulting Agreement • March 23rd, 2022 • Sierra Oncology, Inc. • Pharmaceutical preparations • Massachusetts
THIS CONSULTING AGREEMENT (this “Agreement”) is made effective on the last signature date below (the “Effective Date”), between Sierra Oncology, Inc., a Delaware corporation, having offices at 1820 Gateway Drive, Suite 110 San Mateo, CA 94404 U.S.A. the “Company”), and Mark Kowalski, MD, PhD, an individual, whose address is 10 Priscilla Lane, Winchester, MA, United States (“Consultant”).
